Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to SRPT Full portfolio

Position in SRPT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$36,946,049
-$9,749,300 QoQ
Shares Held
2,055,985
-4.2% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SRPT Over Time

Shares Held

Position Value (USD)

Derivatives in SRPT

reported options exposure · as of Mar 31, 2025
CallValue
$950,918
CallShares
14,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. SRPT ranks #61 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in SRPT

Export CSV
48 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $36,946,049 2,055,985
2026-03-31 $46,695,349 2,145,926
2025-12-31 $36,467,573 1,694,590
2025-09-30 $15,474,925 803,058
2025-06-30 $15,677,190 916,795
2025-03-31 $44,172,690 692,145
2025-03-31 $950,918 14,900
2024-12-31 $74,123,571 609,619
2024-12-31 $2,431,800 20,000
2024-09-30 $849,252 6,800
2024-09-30 $97,792,489 783,029
2024-06-30 $113,981,358 721,401
2024-06-30 $4,708,400 29,800
2024-03-31 $84,597,576 653,465
2024-03-31 $12,816,540 99,000
2023-12-31 $4,908,287 50,900
2023-12-31 $116,909,510 1,212,377
2023-09-30 $11,491,656 94,800
2023-09-30 $11,031,020 91,000
2023-09-30 $63,985,489 527,846
2023-06-30 $1,248,268 10,900
2023-06-30 $51,431,387 449,104
2023-03-31 $77,114,504 559,490
2023-03-31 $11,329,626 82,200
2023-03-31 $8,476,545 61,500
2022-12-31 $49,610,478 382,856
2022-12-31 $3,589,366 27,700
2022-09-30 $42,555,797 384,981
2022-09-30 $773,780 7,000
2022-06-30 $1,431,736 19,100
2022-06-30 $1,956,456 26,100
2022-06-30 $28,593,415 381,449
2022-03-31 $36,549,533 467,864
2022-03-31 $546,840 7,000
2021-12-31 $35,617,293 395,528
2021-12-31 $630,350 7,000
2021-09-30 $39,349,220 425,489
2021-06-30 $35,923,885 462,103
2021-03-31 $38,533,199 517,016
2020-12-31 $65,693,202 385,320
2020-12-31 $8,746,137 51,300
2020-12-31 $3,801,927 22,300
2020-09-30 $63,329,433 450,968
2020-09-30 $547,677 3,900
2020-09-30 $547,677 3,900
2020-06-30 $68,949,724 430,022
2020-03-31 $1,672,722 17,100
2020-03-31 $45,702,675 467,212

Report a Problem

Category
Description
Email (optional, for follow-up)